{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T20:26:54Z","timestamp":1792614414629,"version":"4.5.0"},"reference-count":13,"publisher":"American Medical Association (AMA)","issue":"20","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2019,5,28]]},"DOI":"10.1001\/jama.2019.5358","type":"journal-article","created":{"date-parts":[[2019,5,19]],"date-time":"2019-05-19T15:31:33Z","timestamp":1558279893000},"page":"1993","source":"Crossref","is-referenced-by-count":319,"title":["Effect of a Recombinant Human Soluble Thrombomodulin on Mortality in Patients With Sepsis-Associated Coagulopathy"],"prefix":"10.1001","volume":"321","author":[{"given":"Jean-Louis","family":"Vincent","sequence":"first","affiliation":[{"name":"Department of Intensive Care, Erasme Hospital, Universit\u00e9 libre de Bruxelles, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Francois","sequence":"additional","affiliation":[{"name":"ICU Department, Inserm CIC-1435 & UMR-1092, CHU Dupuytren, Limoges, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Zabolotskikh","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Intensive Care and Transfusiology, Kuban State Medical University, Krasnodar, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mradul Kumar","family":"Daga","sequence":"additional","affiliation":[{"name":"Department of Medicine, Maulana Azad Medical College and associated hospitals, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Baptiste","family":"Lascarrou","sequence":"additional","affiliation":[{"name":"Centre Hospitalier Universitaire de Nantes, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikhail Y.","family":"Kirov","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Intensive Care Medicine, Northern State Medical University, Arkhangelsk, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ville","family":"Pettil\u00e4","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Intensive Care and Pain Medicine, University of Helsinki and Helsinki University Hospital, Helsinki, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Wittebole","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, St Luc University Hospital, Universit\u00e9 Catholique de Louvain, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferhat","family":"Meziani","sequence":"additional","affiliation":[{"name":"Facult\u00e9 de M\u00e9decine, Universit\u00e9 de Strasbourg (UNISTRA), H\u00f4pitaux Universitaires de Strasbourg, Service de R\u00e9animation, Nouvel H\u00f4pital Civil, Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Mercier","sequence":"additional","affiliation":[{"name":"M\u00e9decine Intensive R\u00e9animation, CHRU de Tours, Tours, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzana M.","family":"Lobo","sequence":"additional","affiliation":[{"name":"Intensive Care Division, Hospital de Base, S\u00e3o Jos\u00e9 do Rio Preto, SP, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip S.","family":"Barie","sequence":"additional","affiliation":[{"name":"Departments of Surgery and Medicine, Weill Cornell Medicine, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Crowther","sequence":"additional","affiliation":[{"name":"Department of Medicine, McMaster University and St Joseph\u2019s Hospital, Hamilton, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles T.","family":"Esmon","sequence":"additional","affiliation":[{"name":"Coagulation Biology Laboratory, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jawed","family":"Fareed","sequence":"additional","affiliation":[{"name":"Pathology and Pharmacology, Loyola University Medical Center, Maywood, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Gando","sequence":"additional","affiliation":[{"name":"Acute and Critical Care Center, Sapporo Higashi Tokushukai Hospital, Sapporo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth J.","family":"Gorelick","sequence":"additional","affiliation":[{"name":"Zymo Consulting Group LLC, Newtown Square, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Levi","sequence":"additional","affiliation":[{"name":"Department of Medicine, University College London Hospitals and Cardiometabolic Programme-NIHR UCLH\/UCL BRC, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Paul","family":"Mira","sequence":"additional","affiliation":[{"name":"Universite\u00b4Paris Descartes, Sorbonne Paris Cite\u00b4, Faculte\u00b4 de Me\u00b4-decine Cochin University Hospital, AP-HP, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M.","family":"Opal","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Rhode Island Hospital, Providence, Rhode Island"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Parrillo","sequence":"additional","affiliation":[{"name":"Department of Medicine, New Jersey Medical School of Rutgers University, Hackenseck"},{"name":"Heart and Vascular Hospital, Hackensack University Medical Center, Hackensack, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Russell","sequence":"additional","affiliation":[{"name":"Department of Medicine, Centre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidehiko","family":"Saito","sequence":"additional","affiliation":[{"name":"National Hospital Organization, Nagoya Medical Center, Nagoya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhisa","family":"Tsuruta","sequence":"additional","affiliation":[{"name":"Asahi-Kasei Pharma Corporation, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takumi","family":"Sakai","sequence":"additional","affiliation":[{"name":"Asahi-Kasei Pharma Corporation, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Fineberg","sequence":"additional","affiliation":[{"name":"Asahi-Kasei Pharma America Corporation, Waltham, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the SCARLET Trial Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"16","key":"joi190044r1","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1056\/NEJMoa022139","article-title":"The epidemiology of sepsis in the United States from 1979 through 2000.","volume":"348","author":"Martin","year":"2003","journal-title":"N Engl J Med"},{"issue":"22","key":"joi190044r2","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1056\/NEJMe1203412","article-title":"Septic shock--evaluating another failed treatment.","volume":"366","author":"Wenzel","year":"2012","journal-title":"N Engl J Med"},{"issue":"22","key":"joi190044r3","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1056\/NEJMoa1202290","article-title":"Drotrecogin alfa (activated) in adults with septic shock.","volume":"366","author":"Ranieri","year":"2012","journal-title":"N Engl J Med"},{"issue":"7","key":"joi190044r4","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1097\/CCM.0000000000000325","article-title":"The next generation of sepsis clinical trial designs: what is next after the demise of recombinant human activated protein C?","volume":"42","author":"Opal","year":"2014","journal-title":"Crit Care Med"},{"issue":"5","key":"joi190044r5","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1097\/CCM.0000000000002997","article-title":"Sepsis-associated coagulopathy severity predicts hospital mortality.","volume":"46","author":"Lyons","year":"2018","journal-title":"Crit Care Med"},{"issue":"11","key":"joi190044r6","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1111\/jth.2004.2.issue-11","article-title":"Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation.","volume":"2","author":"Dhainaut","year":"2004","journal-title":"J Thromb Haemost"},{"issue":"4","key":"joi190044r7","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1111\/cdr.2000.18.issue-4","article-title":"ART-123: Recombinant human soluble thrombomodulin.","volume":"18","author":"Mohri","year":"2006","journal-title":"Cardiovasc Drug Rev"},{"issue":"6","key":"joi190044r8","first-page":"1687","article-title":"The inhibitory effect of recombinant human soluble thrombomodulin on initiation and extension of coagulation--a comparison with other anticoagulants.","volume":"82","author":"Mohri","year":"1999","journal-title":"Thromb Haemost"},{"issue":"10","key":"joi190044r9","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1161\/ATVBAHA.107.150631","article-title":"Proteolytic cleavage of high mobility group box 1 protein by thrombin-thrombomodulin complexes.","volume":"28","author":"Ito","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"joi190044r10","doi-asserted-by":"publisher","first-page":"421","DOI":"10.2174\/138945012799424606","article-title":"Thrombomodulin links coagulation to inflammation and immunity.","volume":"13","author":"Morser","year":"2012","journal-title":"Curr Drug Targets"},{"issue":"9","key":"joi190044r11","doi-asserted-by":"publisher","first-page":"e75961","DOI":"10.1371\/journal.pone.0075961","article-title":"Recombinant thrombomodulin protects mice against histone-induced lethal thromboembolism.","volume":"8","author":"Nakahara","year":"2013","journal-title":"PLoS One"},{"issue":"9","key":"joi190044r12","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1097\/CCM.0b013e31828e9b03","article-title":"A randomized, double-blind, placebo-controlled, phase 2b study to evaluate the safety and efficacy of recombinant human soluble thrombomodulin, ART-123, in patients with sepsis and suspected disseminated intravascular coagulation.","volume":"41","author":"Vincent","year":"2013","journal-title":"Crit Care Med"},{"issue":"2","key":"joi190044r13","doi-asserted-by":"publisher","first-page":"R32","DOI":"10.1186\/cc8909","article-title":"Infections of respiratory or abdominal origin in ICU patients: what are the differences?","volume":"14","author":"Volakli","year":"2010","journal-title":"Crit Care"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/\/jama\/article-pdf\/321\/20\/1993\/17611343\/jama_vincent_2019_oi_190044.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T11:04:58Z","timestamp":1559041498000},"score":1,"resource":{"primary":{"URL":"http:\/\/jama.jamanetwork.com\/article.aspx?doi=10.1001\/jama.2019.5358"}},"subtitle":["The SCARLET Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2019,5,28]]},"references-count":13,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2019,5,28]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2019.5358","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5,28]]}}}